Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 175
Efficient and parallel lead discovery by high-throughput kinase profiling
Patrick Zarrinkar, Ph.D.
Ambit Biosciences, San Diego, CA
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
The virtual kinome: The impact of computational methods on lead discovery and optimization
Dr. Jack A. Bikker
Wyeth Research, Pearl River, NY
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Fragment-based drug discovery
Stephen W. Fesik, Ph.D.
Abbott Laboratories, Abbott Park, IL
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
HDACs: An overview
Chairperson: Dr. Edward Seto
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Development of histone deacetylase inhibitors as cancer therapeutics
Ricky W. Johnstone, Ph.D.
Peter MacCallum Cancer Institute, East Melbourne, Australia
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Vorinostat: Preclinical and clinical experience
Christian Steinkuhler, Ph.D.
Merck and Co., Pomezia, Italy
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Nano-sized probes for imaging tumor compartments in vivo
Alexei A. Bogdanov, Ph.D.
University of Massachusetts Medical School, Worcester, MA
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Nanoliposomes for cancer imaging and therapy: Labeling methods and potential applications
Dr. William T. Phillips
UT Health Science Center, San Antonio, TX
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Multifunctional, multimodality cancer imaging based on biodegradable water-soluble synthetic polymers
Chun Li, Ph.D.
UT M. D. Anderson Cancer Center, Houston, TX
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Magnetovaccination and magnetic resonance imaging as a means to investigate cancer vaccine dynamics
Dr. Jeff W. M. Bulte
Johns Hopkins University Medical School, Baltimore, MD
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Introduction
Chairperson: Matthew V. Lorenzi, Ph.D.
Bristol-Myers Squibb Company, Princeton, NJ
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Discovery of small molecule sirtuin inhibitors through a p53 activation assay
Dr. Sonia Lain
University of Dundee, Dundee, United Kingdom
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Selectively targeting protein ubiquitination with an inhibitor of Nedd8 activating enzyme
Teresa Soucy, Ph.D.
Millennium Pharmaceuticals, Cambridge, MA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Targeting notch in cancer gamma secretase inhibitors
Christopher G. Winter, Ph.D.
Merck Research Laboratories, Boston, MA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
The MIRA method for methylation analysis of cancer genomes
Gerd P. Pfeifer, Ph.D.
City of Hope, Duarte, CA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Validation of genome-wide DNA methylation data in CLL using the MassArray system
Chairperson: Christoph Plass, Ph.D.
German Cancer Research Center DKFZ, Heidelberg, Germany
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
DNA methylation profiling by Illumina GoldenGate, Infinium, and Genome Analyzer Technology
Peter W. Laird, Ph.D.
USC/Norris Comprehensive Cancer Center, Los Angeles, CA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Immune correlates of clinical outcomes in dendritic cell vaccination
Anna K. Palucka, M.D., Ph.D.
Baylor Institute for Immunology Research, Dallas, TX
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Immunologic signatures from the tumor microenvironment
Dr. Francesco M. Marincola
National Cancer Institute, Bethesda, MD
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Early detection of cancer based on plasma autoantibody signatures
Samir M. Hanash, M.D., Ph.D.
Fred Hutchinson Cancer Research Center, Seattle, WA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Immunologic biomarkers to predict vaccine efficacy
Chairperson: Mary L. Disis, M.D.
University of Washington, Seattle, WA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
The ras pathway in carcinogenesis
Chairperson: David A. Tuveson, M.D., Ph.D.
CRUK Cambridge Research Institute, Cambridge, United Kingdom
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Feedback loops in the ras pathway: Implications for targeted therapy
Frank McCormick, Ph.D., FRS, DSc (Hon)
University of California Comprehensive Cancer Center, San Francisco, CA
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Targeting mutant KRAS tumors with combined inhibition of RAS effector pathways
Neal Rosen, M.D., Ph.D.
Memorial Sloan-Kettering Cancer Center, New York, NY
from AACR 100th Annual Meeting 2009 on April 18, 2009 10:15 AM-12:15 PM
Fibroblasts as regulators of the tumor microenvironment
Neil A. Bhowmick, Ph.D.
Vanderbilt University, Nashville, TN
from AACR 100th Annual Meeting 2009 on April 18, 2009 1:00 PM-3:00 PM
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 175